Replies to post #181387 on Anavex Life Sciences Corp (AVXL)

[F1ash]

Care to elaborate?

This:

“I wondered if there was some issue with the 30 and 50 mg doses in the AD trial. I think that would be important because apparently only the “higher concentrations” were effective. I figured that the AD trial registration would put the matter to bed if it was a “nonissue”. There was a long delay in even registering the AD trial and, last I checked, when they did register the trial, they did not disclose the dosages. The behavior seems to fit my unproven hypothesis.”